Literature DB >> 34614407

The future of prevention and treatment of diabetes with nutrition in China.

Wei Wei1, Wenbo Jiang1, Tianshu Han1, Maoyi Tian2, Gangqiang Ding3, Ying Li4, Changhao Sun5.   

Abstract

The significant transformation of dietary patterns in China has contributed to an increasing prevalence of type 2 diabetes over the past few decades. In this article, we comprehensively summarize the epidemiological characteristics of diabetes in China and further discuss major nutritional risk factors for diabetes. Although China has committed to combat diabetes through health system reform and national initiatives, the burden of diabetes remains a major challenge, with an increased premature mortality for the population. We therefore provide several recommendations for the nation's future diabetes agenda, with the aim of establishing an environment of healthy nutrition through multi-sectoral government and community engagement, and novel, robust scientific research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34614407     DOI: 10.1016/j.cmet.2021.09.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  2 in total

1.  Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China.

Authors:  Yu An; Yinhui Li; Nannan Bian; Xiaoyu Ding; Xiaona Chang; Jia Liu; Guang Wang
Journal:  Front Nutr       Date:  2022-04-26

2.  Factors correlated with targeted prevention for prediabetes classified by impaired fasting glucose, impaired glucose tolerance, and elevated HbA1c: A population-based longitudinal study.

Authors:  Xiaoyue Zhu; Zhipeng Yang; Zhiliang He; Jingyao Hu; Tianxiu Yin; Hexiang Bai; Ruoyu Li; Le Cai; Haijian Guo; Mingma Li; Tao Yan; You Li; Chenye Shen; Kaicheng Sun; Yu Liu; Zilin Sun; Bei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.